Reilly Coch is an Endocrinology/Metabolic physician affiliated with Cornell University. OpenAlex indexes 7 publications with 549 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
201 Dates Dr
Ithaca, NY 14850
Telephone
607-257-5858Provider last certified this registry record 28 Apr 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- Lilly USA, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79.8%Insulin Analog20.5%Soliqua 100-3328%Lantus Solostar16%Basaglar Kwikpen U-10014%Novolog Flexpen11%Insulin Lispro Kwikpen U-1009%Novolog4%Toujeo Solostar4%Fiasp Flextouch4%Toujeo Max Solostar4%Tresiba Flextouch U-1004%Lantus2%Insulin Lispro2%Part D<11 patientsGLP-1 receptor agonist16.6%Ozempic68%Trulicity17%Mounjaro11%Rybelsus4%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
12.3%l-Thyroxine9.3%Levothyroxine Sodium88%Synthroid12%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.4%Methimazole100%Part D≥18 patients+ 3 more classes in this area
Cardiovascular
3.7%Statin2.5%Rosuvastatin Calcium44%Atorvastatin Calcium36%Simvastatin20%Part D<11 patientsAldosterone antagonist (MRA)0.5%Spironolactone100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”